Article Information
History
- March 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kamil Borkowski1,*,
- Theresa L. Pedersen2,
- Nicholas T. Seyfried3,
- James J. Lah4,
- Allan I. Levey4,
- Chadwick M. Hales4,
- Eric B. Dammer3,
- Colette Blach5,
- Gregory Louie6,
- Rima Kaddurah-Daouk7,
- John W. Newman1,8,9,
- Alzheimer’s Disease Metabolomics Consortium
- 1West Coast Metabolomics Center, Genome Center, University of California Davis, Davis, CA 95616, USA
- 2Dept Food Science and Technology, University of California - Davis, Davis, CA 95616, USA
- 3Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA
- 4Department of Neurology, Emory University, Atlanta, GA, 30329 USA
- 5Duke Molecular Physiology Institute, Duke University, Durham, NC, 27708 USA
- 6Department of Psychiatry and Behavioral Sciences, Duke University, Durham NC 27708, USA
- 7Department of Psychiatry and Behavioral Sciences, Duke Institute for Brain Sciences and Department of Medicine, Duke University, Durham NC 27708, USA
- 8Western Human Nutrition Research Center, United States Department of Agriculture - Agriculture Research Service, Davis, CA 95616, USA
- 9Department of Nutrition, University of California - Davis, Davis, CA 95616, USA
- ↵*Corresponding author: kborkowski{at}ucdavis.edu
Posted March 10, 2021.
Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase and ethanolamides metabolism with Alzheimer’s disease
